Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian
A Conversation with Ultragenyx’s Chief Medical Officer, Camille Bedrosian to discuss Insights into Future LC-FAOD Research. Also hear from Ultragenyx’s Global Metabolic Dietitian, Bridget Reineking on How to Use the Newly FDA Approved Medicine.
Date: 07/25/2020Speaker:
Camille Bedrosian & Bridget Reineking
Listen Now: Click Here
Related Articles
MELAS Spectrum Disorders and Sonlicromanol: Progress Update
Date: 03/18/2022Speaker:
Dr. Jan Smeitink